Is Oruka Therapeutics, Inc. (ORKA) a Buy, Sell, or Hold?
NASDAQ : ORKA
Oruka Therapeutics, Inc. — Analyst Ratings
$94.79 USD
-$1.72 (-1.78%)
- Volume
- 807.22K
- Average Volume
- 1.47M
- Market Capitalization
- $3.55B
- P/E Ratio
- -39.66
- Dividend Yield
- 0.00%
- Price Target
- $155.50
- Year High
- $99.00
- Year Low
- $12.84
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $23.76
Analyst Consensus Summary
Consensus Rating
Sell
9 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-39.0%
vs Current Price
Price Target
$155.50
Average TargetPrice Target Range
Lowest Target
$120.00
-21.0% DOWNSIDE
Average Target
$155.50
Median Estimate
Highest Target
$200.00
-52.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 9
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 9 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Piper Sandler | Yasmeen Rahimi | $180 | $54.7101 | 2026-06-02 08:26 AM | 229.0% |
| Barclays | Etzer Darout | $160 | $80.3548 | 2026-04-27 11:40 AM | 99.1% |